Louis Bessette

Does the Type of Failure and the Choice of the Second Biologic Influence Response and Persistence on Medication in Rheumatoid Arthritis?, Keystone E, Kane K, Kremer JM, Reed G, Movahedi M, Bessette L, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2023, 10.1097/rhu.0000000000002013

Switching between janus kinase inhibitor upadacitinib and adalimumab following insufficient response: Efficacy and safety in patients with rheumatoid arthritis, Song, I.-H., Demasi, R., Song, Y., Li, Y., Enejosa, J., Bessette, L., Zerbini, C., Van Den Bosch, F.E., Thomson, G.T.D., Hall, S., Blanco, R., Fleischmann, R.M., Annals of the Rheumatic Diseases, 2021, 10.1136/annrheumdis-2020-218412

Antidepressant use and 10-year incident fracture risk: The population-based Canadian Multicentre Osteoporosis Study (CaMoS), Rahme, E., Fraser, L.-A., Pickard, L., Ioannidis, G., Kaiser, S., Leslie, W.D., Towheed, T., Kreiger, N., Prior, J., Goltzman, D., Adachi, J., Bessette, L., Papaioannou, A., Abrahamowicz, M., Bernatsky, S., Moura, C., Osteoporosis International, 2014, 10.1007/s00198-014-2649-x

Which advanced treatment should be used following the failure of a first-line anti-TNF in patients with rheumatoid arthritis? 15 years of evidence from the Quebec registry RHUMADATA., Coupal L, Villeneuve É, Sauvageau D, Raynauld JP, Pelletier JP, Nadon V, Massicotte F, Masetto A, Joly-Chevrier M, Ferdinand I, Sauvageau LC, Bessette L, Mohammad Movahedi, Haraoui B, Choquette D, Rheumatology (Oxford, England), 2024, 10.1093/rheumatology/keae283

Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: A systematic literature review, Bykerk, V., Haraoui, B., Bessette, L., Pope, J., Barra, L., Rheumatology, 2011, 10.1093/rheumatology/keq190

Prevalence and predictors of long-term work disability due to carpal tunnel syndrome, Keller, R.B., Mooney, N., Fossel, A.H., Punnett, L., Bessette, L., Lew, R.A., Katz, J.N., American Journal of Industrial Medicine, 1998, 10.1002/(SICI)1097-0274(199806)33:6<543::AID-AJIM4>3.0.CO;2-R

Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study, Laëtitia Michou, Jacques P. Brown, Louis Bessette, Paul R. Fortin, Lucie Ratelle, Narcisse Singbo, Antoine Robert, Wen Qi, Advances in Rheumatology, 2024, 10.1186/s42358-024-00396-6

Psoriasis and smoking: A systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity, Bissonnette, R., Haraoui, B., Gulliver, W.P., Bessette, L., Dutz, J., Keeling, S., Pope, J.E., Lynde, C., Kraft, J., Siu, S., McFarlane, A., McCourt, C., Starnino, T., Fleming, P., Roubille, C., Richer, V., Journal of Cutaneous Medicine and Surgery, 2016, 10.1177/1203475415616073

Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study, Derek Haaland, Odalis Asin-Milan, Adriana Calce, Francois Nantel, Meagan Rachich, Thanu Ruban, Sam Aseer, Proton Rahman, Regan Arendse, Pauline Boulos, Louis Bessette, Patient Preference and Adherence, 2025, 10.2147/ppa.s516794

Peak bone mass from longitudinal data: Implications for the prevalence, pathophysiology, and diagnosis of osteoporosis, Vigna, Y., Lentle, B., Patel, M., Allan, J., Thingvold, J., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Poliquin, S., Hanley, D.A., Prior, J.C., Josse, R.G., Davison, K.S., Tenenhouse, A., Kreiger, N., Joseph, L., Jackson, S., Langsetmo, L., Goltzman, D., Berger, C., Journal of Bone and Mineral Research, 2010, 10.1002/jbmr.95

Major stressors in the year prior to disease onset affects RA characteristics at baseline and 12 months: results from the Canadian Early Arthritis Cohort (CATCH), Bartlett, Susan, Bykerk, Vivian, Keystone, Edward, Hazlewood, Glen, Hitchon, Carol, Pope, Janet, Thorne, Carter, Tin, Diane, Bessette, Louis, Boires, Gilles, Andersen, Kathleen, Valois, Marie-France, Schieir, Orit, Andersen, Nicole, Quality of Life Research, 2020

Experience with tofacitinib in Canada: Patient characteristics and treatment patterns in rheumatoid arthritis over 3 years, Haraoui, B., Gold, D., Crooks, M., Gruben, D., Woolcott, J., Fallon, L., Jones, N., Bessette, L., Pope, J., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/kez324

ACHIEVING A LOW DISEASE STATE WITHIN FIRST 3 MONTHS IN EARLY RHEUMATOID ARTHRITIS RESULTS IN LOWER FATIGUE OVER 5 YEARS, Pope, Janet, Bykerk, Vivian, Thorne, Carter, Hitchon, Carol, Keystone, Edward, Tin, Diane, Hazlewood, Glen, Boire, Gilles, Bessette, Louis, Bartlett, Susan J., Schieir, Orit, Holdren, Melissa, Annals of the Rheumatic Diseases, 2019, 10.1136/ANNRHEUMDIS-2019-EULAR.4414

Maine carpal tunnel study: Outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort, Mooney, N.A., Fossel, A.H., Bessette, L., Rogers, W.D., Simmons, B.P., Keller, R.B., Katz, J.N., Journal of Hand Surgery, 1998, 10.1016/S0363-5023(98)80058-0

Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study, John S. Sampalis, Manprit Chohan, Anne-Julie Gaudreau, Jennifer Jelley, Sabeen Anwar, Dafna D. Gladman, Proton Rahman, Maqbool Sheriff, Carter Thorne, Louis Bessette, Vinod Chandran, Rheumatology and Therapy, 2024, 10.1007/s40744-024-00641-w

Stressful life events are common in the year prior to RA onset and are associated with worse symptoms and QOL, Bartlett, Susan, Bykerk, Vivian, Keystone, Ed, Tin, Diane, Hazlewood, Glen, Hitchon, Carol, Pope, Janet, Thorne, Carter, Bessette, Louis, Boire, Gilles, Valois, Marie-France, Schieir, Orit, Andersen, Nicole, Quality of Life Research, 2019

Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts., OBRI, RHUMADATA, CATCH Investigators, and the Rheum4U Team, Claire Barber, Laurie Proulx, Dawn P. Richards, Spencer N, Sasha Bernatsky, Deborah Marshall, Mosher D, Orit Schieir, Louis Coupal, Vivian P. Bykerk, MD FRCPC, Denis Choquette, Mohammad Movahedi, Li X, Bombardier C, Glen Hazlewood, The Journal of rheumatology, 2021, 10.3899/jrheum.201688

The current economic burden of illness of osteoporosis in Canada, Tarride, J., Pericleous, L., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S.N., Leslie, W.D., Von Keyserlingk, C., Burke, N., Hopkins, R.B., Osteoporosis International, 2016, 10.1007/s00198-016-3631-6

The impact of two educational interventions on osteoporosis diagnosis and treatment after fragility fracture: A population-based randomized controlled trial, Brown, J.P., Ste-Marie, L.G., Roy, S., Jean, S., Davison, K.S., Bessette, L., Osteoporosis International, 2011, 10.1007/s00198-011-1533-1

A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort, Vivian P. Bykerk, J Carter Throne, Diane Tin, Janet Pope, Edward C. Keystone, Carol Hitchon, Glen Hazlewood, Boulos Haraoui, Gilles Boire, Louis Bessette, Susan J. Bartlett, Marie‐France Valois, Orit Schieir, Kathleen M. Andersen, ACR Open Rheumatology, 2022, 10.1002/acr2.11334

Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials, Pope, J.E., Dutz, J., Keeling, S., Gulliver, W., Lynde, C., Kraft, J., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Bessette, L., Bissonnette, R., Haraoui, B., Siu, S., Arthritis Care and Research, 2015, 10.1002/acr.22519

MAPPING REAL-WORD RHEUMATOID ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA, Rachich, Meagan, Nantel, Francois, Asin-Milan, Odalis, Lehman, Allen J., Rampakakis, Emmanouil, Rahman, Proton, Bessette, Louis, Olsynski, Wojciech, Keystone, Ed, Internal Medicine Journal, 2020

Patients' preferences and their relationship with satisfaction following carpal tunnel release, Katz, J.N., Fossel, A.H., Simmons, B.P., Liang, M.H., Keller, R.B., Bessette, L., Journal of Hand Surgery, 1997, 10.1016/S0363-5023(97)80117-7

Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort, Zummer, M., Villeneuve, E., Rubin, L., Penney, C., Panopoulos, P., Nair, B., Joshi, R., Jamal, S., Jamal, S., Haraoui, P., Haaland, D., Fallavollita, S., Colmegna, I., Bessette, L., Baron, M., Bernatsky, S., Bykerk, V.P., Tin, D., Keystone, E.C., Hazlewood, G.S., Haraoui, B., Boire, G., Hitchon, C.A., Pope, J.E., Bartlett, S.J., Thorne, C., Valois, M.-F., Schieir, O., Moura, C.S., Arthritis Care and Research, 2020, 10.1002/acr.23927

APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN ANKYLOSING SPONDYLITIS PATIENTS, Lehman, Allen J., Nantel, Francois, Rachich, Meagan, Asin-Milan, Odalis, Rampakakis, Emmanouil, Rahman, Proton, Bessette, Louis, Inman, Robert, Maksymowych, Walter, Internal Medicine Journal, 2020

Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study - Comparing site and age-specific risks in women and men, Jackson, S., Morin, S., Richards, B., ElhamRahme, Andjelic, N., Vigna, Y.M., Patel, M., Allan, J., Boyd, S., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, Wojciech, P., Pickard, L., Gardner-Bray, B., Cheung, A.M., Jamal, S., Rees-Milton, K., Hopman, W., Gendreau, M., Bessette, L., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Robertson, L., Bastien, D., Mailloux, L., Lentle, B., Dumont, S., Godmaire, S., Poliquin, S., Tenenhouse, A., Kreiger, N., Leslie, W.D., Brown, J.P., Josse, R.G., Towheed, T., Anastassiades, T., Papaioannou, A., Adachi, J.D., Kaiser, S.M., Kovacs, C.S., Goltzman, D., Berger, C., Lentle, B.C., Langsetmo, L., Prior, J.C., Bone, 2015, 10.1016/j.bone.2014.10.026

Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data., Bessette L, Bombardier C, Keystone E, Coupal L, Choquette D, Movahedi M, Clinical and experimental rheumatology, 2024, 10.55563/clinexprheumatol/6qobnr

Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents, Vigna, Y., Prior, J.C., Allan, J., Thingvold, J., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Poliquin, S., Goltzman, D., Tenenhouse, A., Kreiger, N., Josse, R., Davison, K.S., Hanley, D.A., Joseph, L., Langsetmo, L., Berger, C., CMAJ, 2008, 10.1503/cmaj.071416

Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over, Lachaine, J., Rahme, E., Bernatsky, S., Bessette, L., Roussy, J.-P., Osteoporosis International, 2013, 10.1007/s00198-013-2321-x

Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE Study., Bessette L, de Nijs R, van Hoogstraten H, Qiu C, Bergman M, Gottenberg JE, Alan Kivitz, Rheumatology and therapy, 2024, 10.1007/s40744-024-00715-9

Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid Arthritis, Zummer, M., Villeneuve, E., Thorne, C., Rubin, L., Pope, J., Panopoulos, P., Nair, B., Keystone, E., Joshi, R., Jamal, S., Hitchon, C., Hazlewood, G., Haraoui, P., Haaland, D., Fallavollita, S., Colmegna, I., Bykerk, V., Boire, G., Bessette, L., Baron, M., Pope, J.E., Bykerk, V.P., Thorne, C., Tin, D., Keystone, E.C., Hitchon, C., Hazlewood, G., Boire, G., Bessette, L., Bartlett, S.J., Valois, M.F., Schieir, O., Fatima, S., Arthritis and Rheumatology, 2021, 10.1002/art.41513

Dr. Roubille, et al reply, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Journal of Rheumatology, 2016, 10.3899/jrheum.151347

Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective, Zlateva, G., Ho, J., Roussy, J.-P., Mittmann, N., Risebrough, N., Bessette, L., Journal of Medical Economics, 2009, 10.3111/13696990903288970

Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study, Laliberté, M.-C., Latour, M.G., Gazel, S., Gaetano, T., Oraichi, D., Millson, B., Gerega, S.K., Lebovic, G., Shear, N.H., Thorne, C., Bessette, L., Marshall, J.K., Clinical Therapeutics, 2018, 10.1016/j.clinthera.2018.02.001

Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis, Brown, J.P., Moore, L., Ste-Marie, L.-G., Bessette, L., Jean, S., Beaudoin, C., Osteoporosis International, 2016, 10.1007/s00198-016-3607-6

Real-World Incidence and Determinants of Infection in Patients With Rheumatoid Arthritis Treated With Golimumab After a Median Follow-Up Time of 27 Months., Marrache AM, Asin-Milan O, Nantel F, Rachich M, Lehman AJ, Rampakakis E, Purvis J, Kelsall J, Rahman P, Bessette L, The Journal of rheumatology, 2023, 10.3899/jrheum.2022-1283

The burden of osteoporotic fractures beyond acute care: The Canadian Multicentre Osteoporosis Study (CaMos), Lentle, B.C., Vigna, Y., Patel, M., Prior, J.C., Allan, J., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S.A., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Berger, C., Godmaire, S., Poliquin, S., Tenenhouse, A., Kreiger, N., Goltzman, D., Papaioannou, A., Papadimitropoulos, E., Adachi, J., Pickard, L., Oremus, M., Raina, P., Kaffashian, S., Age and Ageing, 2011, 10.1093/ageing/afr085

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry, Nantel, F., Lehman, A.J., Rampakakis, E., Teo, M., Bessette, L., Haaland, D., Starr, M., Rahman, P., BMC Rheumatology, 2020, 10.1186/s41927-020-00158-z

Sex differences in pain scores and localization in inflammatory arthritis: A systematic review and metaanalysis, Bykerk, V., Thorne, C., Mosher, D., Hochman, J., Haraoui, B., Pope, J.E., Kung, T., Kalache, F., Steiman, A., LeClercq, S., Flanagan, C., Bessette, L., Barnabe, C., Journal of Rheumatology, 2012, 10.3899/jrheum.111393

Algorithms can be used to identify fragility fracture cases in physician-claims databases, Brown, J.P., Dodin, S., Bessette, L., Morin, S., Belzile, É., Candas, B., Jean, S., Osteoporosis International, 2012, 10.1007/s00198-011-1559-4

What are the rheumatology educational preferences of family medicine residents? A descriptive study, Michou, L., Bessette, L., Rheault, C., Julien, A.-S., Lagacé, S., Clinical Rheumatology, 2020, 10.1007/s10067-020-05018-2

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)., COAST-Y study group, Filip Van den Bosch, Carlier H, Adams D, Liu Leage S, Li X, Hojnik M, Rahman P, Denis Poddubnyy, Gensler LS, Robert Landewé, Annals of the rheumatic diseases, 2021, 10.1136/annrheumdis-2020-219717

Loss of health related quality of life following low-trauma fractures in the elderly, Hopkins, R.B., Muratov, S., Pericleous, L., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S.N., Leslie, W.D., Burke, N., Tarride, J.-E., BMC Geriatrics, 2016, 10.1186/s12877-016-0259-5

History of fractures for prediction of a future fracture in individuals from the general population, Brown, Jacques P., Ste-Marie, Louis-Georges, Bessette, Louis, Gamache, Philippe, Moore, Lynne, Jean, Sonia, Beaudoin, Claudia, Journal of Bone and Mineral Research, 2017

Sharing ongoing care with primary care physicians opens up opportunity for timelier and earlier care by rheumatologists for patients with new inflammatory polyarthritis, Michou, L., Fortin, P.R., Bessette, L., Julien, A.-S., Nguyen, P., Journal of Rheumatology, 2018, 10.3899/jrheum.170494

Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE., Mysler E, Chan K, Khan N, McDearmon-Blondell E, Penn SK, Song Y, Bessette L, Filip Van den Bosch, Ricardo Blanco, Roy Fleischmann, Rheumatology and therapy, 2024, 10.1007/s40744-024-00658-1

The Burden of Osteoporotic Fracture: Epidemiology and Health-care Utilisation in Older Adults, 1997-2010, Brown, Jacques P., Gagne, Mathieu, Morin, Suzanne, Belzile, Etienne, Bessette, Louis, Gamache, Philippe, Jean, Sonia, Journal of Bone and Mineral Research, 2013

Identifying flares in rheumatoid arthritis: Reliability and construct validation of the OMERACT RA Flare Core Domain Set, Zummer, M., Thorne, C., Rubin, L., Penney, C., Nair, B., Lyddell, C., Larche, M., Kraishi, M., Kinkhoff, A., Colmegna, I., Bessette, L., Bensen, W., Baron, M., Akhavan, P., Ahluwalia, V., Voshaar, M.S., Pohl, C., Orbai, A.-M., Montie, P., May, J.E., Lyddiatt, A., Guillemin, F., Fautrel, B., Den Broeder, A., Boonen, A., Bartlett, S.J., Thorne, J.C., Tin, D., Pope, J., Keystone, E.C., Jamal, S., Hitchon, C., Haraoui, B., Boire, G., Woodworth, T., March, L., Leong, A., Hewlett, S., Furst, D.E., Christensen, R., Alten, R., Lin, D., Choy, E.H., Bingham, C.O., Bykerk, V.P., RMD Open, 2016, 10.1136/rmdopen-2015-000225

Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture, Lentle, B.C., Vigna, Y., Patel, M., Allan, J., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A., Gardner-Bray, B., Murray, T., Jamal, S.A., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Berger, C., Godmaire, S., Poliquin, S., Tenenhouse, A., Kreiger, N., Goltzman, D., Eisman, J.A., Hanley, D.A., Adachi, J.D., Josse, R.G., Morin, S., Center, J.R., Prior, J.C., Kovacs, C.S., Nguyen, N.D., Nguyen, T.V., Langsetmo, L., CMAJ, 2011, 10.1503/cmaj.100458

Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study, , 1911

Factors influencing diagnosis and treatment of osteoporosis following a fragility fracture, Ste-Marie, Louis-Georges, Bessant, Jennifer, Baranci, Mirela, Beaulieu, Michele, Davison, K. Shawn, Jean, Sonia, Brown, Jacques P., Bessette, Louis, The Journal of Rheumatology, 2008

Effect of biologics on depressive symptoms in patients with psoriasis: A systematic review, Gulliver, W.P., Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Pope, J.E., Lynde, C., Kraft, J., Siu, S., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Fleming, P., Journal of the European Academy of Dermatology and Venereology, 2015, 10.1111/jdv.12909

CURATA: A patient health management program for the treatment of osteoarthritis in Québec: An integrated approach to improving the appropriate utilization of anti-inflammatory/analgesic medications, Carrier, R., Bessette, L., Rahme, E., Choquette, D., Beaulieu, M., American Journal of Managed Care, 2004

Calcium and Vitamin D intake and mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos), Andjelic, N., Allan, J., Thingvold, J., Olszynski, W.P., Pickard, L., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Dumont, J., Bessette, L., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Dumont, S., Godmaire, S., Tenenhouse, A., Goltzman, D., Davison, K.S., Leslie, W.D., Adachi, J.D., Papaioannou, A., Josse, R.G., Towheed, T., Anastasiades, T., Brown, J.P., Patel, M.S., Lentle, B., Prior, J.C., Hodsman, A., Morin, S.N., Genest, J., Whiting, S.J., Jamal, S.A., Hanley, D.A., Kovacs, C.S., Kreiger, N., Berger, C., Langsetmo, L., Journal of Clinical Endocrinology and Metabolism, 2013, 10.1210/jc.2013-1516

An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis, Martel-Pelletier, J., Paiement, P., Pavelka, K., Morin, F., Dokoupilova, E., Bessette, L., Dorais, M., Raynauld, J.-P., Pelletier, J.-P., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/keaa072

Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis, Michou, L., Fortin, P.R., Bessette, L., Brown, J.P., Beaudoin, C., Ikic, A., Joint Bone Spine, 2015, 10.1016/j.jbspin.2014.12.005

Changes in body mass index in Canadians over a five-year period: Results of a prospective, population-based study, Vigna, Y., Allan, J., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A.A., Adachi, J.D., Kreiger, N., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Tenenhouse, A., Goltzman, D., Anastassiades, T., Towheed, T., Poliquin, S., Harrison, M., Prior, J.C., Barr, S.I., Joseph, L., Berger, C., Leroux, C., Hopman, W.M., BMC Public Health, 2007, 10.1186/1471-2458-7-150

The association between body mass index and health-related quality of life: Data from CaMos, a stratified population study, Vigna, Y., Allan, J., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Kreiger, N., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Tenenhouse, A., Godmaire, S., Goltzman, D., Anastassiades, T., Towheed, T., Poliquin, S., Prior, J.C., Gao, Y., Barr, S.I., Joseph, L., Berger, C., Hopman, W.M., Quality of Life Research, 2007, 10.1007/s11136-007-9273-6

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial, Camp, H.S., Pangan, A.L., Othman, A.A., Zhou, Y., Li, Y., Bessette, L., Kivitz, A., Van den Bosch, F., Kremer, J.M., Burmester, G.R., The Lancet, 2018, 10.1016/S0140-6736(18)31115-2

The care gap in diagnosis and treatment of women with a fragility fracture, Brown, J.P., Bessant, J., Baranci, M., Beaulieu, M., Davison, K.S., Jean, S., Ste-Marie, L.-G., Bessette, L., Osteoporosis International, 2008, 10.1007/s00198-007-0426-9

Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: Analysis from a Canadian administrative database, Maslova, K., Nantel, F., Tkaczyk, C., Bell, M.J., Bessette, L., Bhoi, P., BMJ Open, 2017, 10.1136/bmjopen-2017-015872

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial, Genovese, M.C., Othman, A.A., Zhou, Y., Li, Y., Ostor, A.J., Durez, P., Peterfy, C., Bessette, L., Mysler, E., Song, I.-H., Pangan, A.L., Fleischmann, R., Arthritis and Rheumatology, 2019, 10.1002/art.41032

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial, Poor, G., Drescher, E., Cseuz, R., Balazs, T., Rebrov, A., Ershova, O., Yakushin, S., Stanislav, M., Shmidt, E., Matsievskaya, G., Nurmohamed, M., Griep, E., van de Sande, M., Wojciechowski, R., Racewicz, A., Dudek, A., Blicharski, T., Szymanska, M., Rubbert-Roth, A., Poddubnyy, D., Neeck, G., Takakubo, Y., Matsui, K., Goto, H., Atsumi, T., Hatta, K., Koyama, Y., Matsumoto, Y., Ueki, Y., Inui, K., Dobashi, H., Tada, K., Kishimoto, M., Taniguchi, Y., Malcova, M., Moravcova, R., Dvorak, Z., Lan, J.-L., Hsieh, S.-C., Chen, Y.-C., Chen, H.-A., Lee, S.-H., Shin, K., Park, M.-C., Lee, S.H., Lee, E.B., Lee, C.K., Kim, T.-H., Kang, S.W., Ju, J.H., Lee, Y.-A., Hong, S.-J., Rizo Rodriguez, J.C., Ramos Remus, C., Pacheco Tena, C., Skinner, C., Duran Barragan, S., Cons-Molina, F., Barrera Rodriguez, A.A., Rahman, P., Morin, F., Bessette, L., Thai, C., Diegel, R., Roseff, R., Reveille, J., Querubin, R., Peters, E., Mehta, D., Kaine, J., Ince, A., Howell, M., Greenwald, M., Gladstein, G., Flint, K., Churchill, M., Carlier, H., Pangallo, B., Adams, D.H., Krishnan, E., Zhao, F., Landewé, R., Tomita, T., Sieper, J., Van den Bosch, F., Maksymowych, W.P., Deodhar, A., Mease, P., Dougados, M., Cheng-Chung Wei, J., van der Heijde, D., The Lancet, 2018, 10.1016/S0140-6736(18)31946-9

Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: A 2-year multicentre exploratory study, Martel-Pelletier, J., Abram, F., Paiement, P., Dorais, M., Delorme, P., de Brum-Fernandes, A.J., Morin, F., Bessette, L., Beaulieu, A.D., Raynauld, J.-P., Pelletier, J.-P., Arthritis Research and Therapy, 2016, 10.1186/s13075-016-1149-0

Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: A randomised, double-blind, placebo-controlled pilot study using MRI, Pelletier, J.-P., Dorais, M., Abram, F., Morin, F., Bessette, L., Beaulieu, A., Martel-Pelletier, J., Raynauld, J.-P., Wildi, L.M., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.140848

The presence of meniscal lesions is a strong predictor of neuropathic pain in symptomatic knee osteoarthritis: A cross-sectional pilot study, Pelletier, J.-P., Martel-Pelletier, J., Beaulieu, A.D., Bessette, L., Delorme, P., Dorais, M., Paiement, P., Abram, F., Raynauld, J.-P., Roubille, C., Arthritis Research and Therapy, 2014, 10.1186/s13075-014-0507-z

Characterizing Nonarticular Pain at Early Rheumatoid Arthritis Diagnosis: Evolution Over the First Year of Treatment and Impact on Remission in a Prospective Real-World Early Rheumatoid Arthritis Cohort., Canadian Early Arthritis Cohort Investigators, Bykerk VP, Susan J. Bartlett, Janet Pope, Bessette L, Thorne C, Tin D, Bindee K, Carol Hitchon, Hugues Allard-Chamard, Glen Hazlewood, Gilles Boire, Butler MA, Valois MF, Schieir O, Yvonne Lee, Charis Meng, Arthritis & rheumatology (Hoboken, N.J.), 2024, 10.1002/art.43049

Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study, Zummer, M., Villeneuve, E., Tremblay, J.L., Rubin, L., Penney, C., Nair, B., Lyddell, C., Larche, M., Kuriya, B., Joshi, R., Hazlewood, G., Haaland, D., Fallavollita, S., Colmegna, I., Bykerk, V., Bessette, L., Baron, M., Barnabe, C., Barber, C., Barra, L., Akhavan, P., Ahluwalia, V., Bykerk, V.P., Goodman, S.M., Haraoui, B., Keystone, E.C., Tin, D., Thorne, J.C., Jamal, S., Hitchon, C., Pope, J.E., Boire, G., Andersen, K.M., Schieir, O., Bartlett, S.J., Schulman, E., Arthritis Care and Research, 2018, 10.1002/acr.23457

2014 update of the canadian rheumatology association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part II: Specific management recommendations, Inman, R.D., Gladman, D.D., Rahman, P., Thorne, C., Mallinson, M., Adams, K., Keen, K.J., Flanagan, C., Mosher, D., Bessette, L., Chandran, V., Haroon, N., Tse, S.M.L., Chan, J., Rohekar, S., Journal of Rheumatology, 2015, 10.3899/jrheum.141001

An integrated approach to improving appropriate use of anti-inflammatory medication in the treatment of osteoarthritis in Québec (Canada): The CURATA model, Thivierge, R.L., Rahme, E., Choquette, D., Bessette, L., Fournier, C., Paquette, D., Beaulieu, M., Labelle, M., Medical Teacher, 2004, 10.1080/0142159042000218669

Drs. Bessette and Kinch reply, Cassandra D. Kinch, Louis Bessette, The Journal of Rheumatology, 2023, 10.3899/jrheum.220909

Direct medical resource utilization associated with osteoporosis-related nonvertebral fractures in postmenopausal women, Brown, J.P., Dodin, S., Morin, S., Shawn Davison, K., Candas, B., Belzile, E.L., Bessette, L., Jean, S., Journal of Bone and Mineral Research, 2013, 10.1002/jbmr.1756

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?, Lehman AJ, Marrache AM, Rachich M, Asin-Milan O, Rampakakis E, Rahman P, Bessette L, Inman RD, Maksymowych WP, Arthritis research & therapy, 2023, 10.1186/s13075-023-03055-1

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib, Wollenhaupt, J., Fleishaker, D., Szumski, A., Shapiro, A.B., Woolcott, J., Wang, L., Azevedo, V.F., Nash, P., Bessette, L., Gold, D., Dikranian, A., Rheumatology and Therapy, 2021, 10.1007/s40744-021-00405-w

Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis,Évaluation de l'impact d'une brochure d'information sur la connaissance des complications dans la sclérodermie systémique, Michou, L., Fortin, P.R., Bessette, L., Brown, J.P., Beaudoin, C., Ikic, A., Revue du Rhumatisme (Edition Francaise), 2015, 10.1016/j.rhum.2015.04.001

Association between change in BMD and fragility fracture in women and men, Vigna, Y., Lentle, B., Allan, J., Thingvold, J., Josse, B., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Poliquin, S., Goltzman, D., Tenenhouse, A., Kreiger, N., Prior, J.C., Josse, R.G., Davison, K.S., Hanley, D.A., Joseph, L., Langsetmo, L., Berger, C., Journal of Bone and Mineral Research, 2009, 10.1359/jbmr.081004

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: A systematic review and meta-analysis, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Pope, J., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2014-206624

A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia, Lew, R.A., Fossel, A.H., Carette, S., Bessette, L., Scandinavian Journal of Rheumatology, 1998, 10.1080/030097498440976

Treating rheumatoid arthritis to target: A Canadian physician survey, Wade, J., Thorne, C., Le Clercq, S., Bessette, L., Bensen, W., Haraoui, B., Journal of Rheumatology, 2012, 10.3899/jrheum.111134

Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis, Dupont, D., Maclean, R., Thorne, C., Rahman, P., Haraoui, B., Bessette, L., Beresniak, A., Russell, A., Clinical Rheumatology, 2009, 10.1007/s10067-008-1060-4

Direct medical costs attributable to peripheral fractures in Canadian post-menopausal women, Brown, J.P., Ste-Marie, L.G., Davison, K.S., Belzile, E.L., Lapointe-Garant, M.-P., Jean, S., Bessette, L., Osteoporosis International, 2012, 10.1007/s00198-011-1785-9

Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study, West, C.R., Viktrup, L., Tive, L., Prucka, W.R., Pixton, G., Brown, M.T., Davignon, I., Bessette, L., Khan, A., Schnitzer, T.J., Seminars in Arthritis and Rheumatism, 2020, 10.1016/j.semarthrit.2020.03.004

Prognostic value of a hand symptom diagram in surgery for carpal tunnel syndrome, Katz, J.N., Mooney, N., Fossel, A.H., Simmons, B.P., Lew, R.A., Keller, R.B., Bessette, L., Journal of Rheumatology, 1997

How to attract trainees, a pan-canadian perspective: Phase 1 of the "training the rheumatologists of tomorrow" project, Crawshaw, D., Lohfeld, L., Yacyshyn, E., Shojania, K., Robinson, D., Pope, J., Khalidi, N., Hazel, E., Bessette, L., Barr, S., Bakowsky, V., Cividino, A., Journal of Rheumatology, 2016, 10.3899/jrheum.150314

An Open-Label Pilot Study Evaluating by Magnetic Resonance Imaging the Potential for a Disease-Modifying Effect of Celecoxib Compared to a Modelized Historical Control Cohort in the Treatment of Knee Osteoarthritis, Pelletier, J.-P., Abram, F., Haraoui, B., Choquette, D., Morin, F., Bessette, L., Beaulieu, A., Martel-Pelletier, J., Raynauld, J.-P., Seminars in Arthritis and Rheumatism, 2010, 10.1016/j.semarthrit.2009.10.003

Factors influencing the treatment of osteoporosis following fragility fracture, Brown, J.P., Ste-Marie, L.-G., Davison, K.S., Roy, S., Jean, S., Bessette, L., Osteoporosis International, 2009, 10.1007/s00198-009-0898-x

The impact of educational interventions on modifiable risk factors for osteoporosis after a fragility fracture, Brown, J.P., Ste-Marie, L.-G., Jean, S., Bessette, L., Beaudoin, C., Osteoporosis International, 2014, 10.1007/s00198-014-2618-4

Sustainability of Response Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: Results Through 3 Years from the SELECT-COMPARE Trial, Fleischmann, Roy, Suboticki, Jessica, Song, Yanna, Shaw, Tim, Song, In-Ho, Bessette, Louis, Combe, Bernard, Buch, Maya, Kavanaugh, Arthur, Nash, Peter, Arthritis & Rheumatology, 2021

CURATA: A patient health management program for the treatment of osteoarthritis in Quebec: An integrated approach to improving the appropriate utilization of anti-inflammatory/analgesic medications, Carrier, R, Bessette, L, Rahme, E, Choquette, D, Beaulieu, M, American Journal of Managed Care, 2004

Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis., An-Ping Huo, Michael J. Nissen, Janos B, Liu-Leage S, Bolce R, Panni T, Wickersham P, Bessette L, Lukas C, Sofia Ramiro, RMD open, 2024, 10.1136/rmdopen-2024-004429

Barriers to, Facilitators of, and Interventions to Support Treat‐to‐Target Implementation in Rheumatoid Arthritis: A Systematic Review, Maya H. Buch, Andrew Östör, Ennio G. Favalli, Ricardo M. Xavier, Louis Bessette, Laure Gossec, Arthritis Care & Research, 2024, 10.1002/acr.25408

Safety profile of upadacitinib in rheumatoid arthritis: Integrated analysis from the SELECT phase III clinical programme, Burmester, G.R., Enejosa, J.V., Hendrickson, B., Khan, N., Zhang, Y., Bessette, L., Tanaka, Y., Zerbini, C.A.F., Winthrop, K.L., Van Vollenhoven, R.F., Cohen, S.B., Annals of the Rheumatic Diseases, 2021, 10.1136/annrheumdis-2020-218510

Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: A population-based study, Rahme, E., Nedjar, H., Bessette, L., Bernatsky, S., Machado, M.A.D.Á., BMC Musculoskeletal Disorders, 2016, 10.1186/s12891-016-1142-4

Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid Arthritis., Bykerk V, Susan J. Bartlett, Janet Pope, Bessette L, Thorne C, Tin D, Keystone E, Carol Hitchon, Hazlewood G, Gilles Boire, Butler M, Valois MF, Schieir O, Yvonne Lee, Charis Meng, ACR open rheumatology, 2024, 10.1002/acr2.11658

Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Pope, J., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Journal of Rheumatology, 2015, 10.3899/jrheum.141112

A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs., Baer PA, Liazoghli D, Girard T, Fournier PA, Sholter D, Naik L, Florica B, Bessette L, Rheumatology and therapy, 2024, 10.1007/s40744-024-00696-9

2014 update of the canadian rheumatology association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. part i: Principles of the management of spondyloarthritis in Canada, Inman, R.D., Gladman, D.D., Rahman, P., Thorne, C., Mallinson, M., Adams, K., Keen, K.J., Flanagan, C., Mosher, D., Bessette, L., Chandran, V., Haroon, N., Tse, S.M.L., Chan, J., Rohekar, S., Journal of Rheumatology, 2015, 10.3899/jrheum.141000

Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis, Zummer, M., Klinkhoff, A., Lyddell, C., Penney, C., Ahluwahlia, V., Colmegna, I., Larche, M., Akhavan, P., Bessette, L., Rubin, L., Bensen, W., Keystone, E.C., Bartlett, S., Baron, M., Bykerk, V., Keystone, E., Jamal, S., Hitchon, C., Tin, D., Thorne, J.C., Haraoui, B., Boire, G., Pope, J., Xiong, J., Kuriya, B., Schieir, O., Lin, D., Clinical and Experimental Rheumatology, 2017

Late onset leflunomide-induced cutaneous ulcers in a seronegative arthritis patient: A case report., Veillette H, Bessette L, Grenier PO, Couture-Lapointe C, SAGE open medical case reports, 2023, 10.1177/2050313x231195480

An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs, Sampalis, J.S., Haraoui, B., Lazovskis, J., Bessette, L., Vaillancourt, J., Rampakakis, E., Pope, J., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/kez470

High Body Mass Index Is a Risk Factor for Low Trauma Fractures in Women Who Have Sustained an Upper Arm or Lower Leg Fracture, Brown, Jacques P., Ste-Marie, Louis-Georges, Bessette, Louis, Jean, Sonia, Beaudoin, Claudia, Journal of Bone and Mineral Research, 2014

Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment, Collier, D., Isaila, M., Poulin-Costello, M., Grantab, R., Kaliyaperumal, A., Kivitz, A.J., Khraishi, M., Bessette, L., Rheumatology and Therapy, 2017, 10.1007/s40744-017-0079-x

The burden of illness of osteoporosis in Canadian men, Goeree, R., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S., Leslie, W.D., Hopkins, R., Guo, N., Tarride, J.-E., Journal of Bone and Mineral Research, 2012, 10.1002/jbmr.1615

Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice, Axel J. Hueber, Louis Bessette, Björn Fritz, Nikola Baschuk, Katharina Jeromin, Tanya Girard, Marie-Claude Laliberté, Martin Bohl-Bühler, Sabine Reckert, Xenofon Baraliakos, Stephanie G. Werner, Rheumatology and Therapy, 2023, 10.1007/s40744-023-00589-3

Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry, Coupal, L., Raynauld, J.-P., Postema, R., Haraoui, B., Alemao, E., Bessette, L., Choquette, D., Arthritis Research and Therapy, 2019, 10.1186/s13075-019-1917-8

Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: A placebo-controlled trial, Blanchette, C., Bensen, W., Bell, M., Thorne, C., Bykerk, V., Frémont, P., Morin, F., Bessette, L., Tardif, J., Moffet, H., Carette, S., Arthritis and Rheumatism, 2003, 10.1002/art.10954

Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD, Lentle, B.C., Vigna, Y., Prior, J.C., Allan, J., Thingvold, J., Davison, K.S., Pickard, L., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Berger, C., Godmaire, S., Poliquin, S., Tenenhouse, A., Jamal, S.A., Olszynski, W.P., Papaioannou, A., Josse, R., Kreiger, N., Hanley, D.A., Adachi, J.D., Kovacs, C.S., Goltzman, D., Langsetmo, L., Journal of Bone and Mineral Research, 2009, 10.1359/jbmr.090319

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study, de Morales, S.V., Ximenes, A.C., Radominski, S.C., Pinto, L.T., Pascual-Ramos, V., Melazzi, A.C.C., Keiserman, M.W., Jauregui, E.A., Hernandez, J.D.M., Jaller Raad, J.J., Maldonado-Lopez, M.C., Escalante, W.J.O., Cardiel-Rios, M.H., Brenol, J.C.T., de Freitas Zerbini, C.A., Vitek, P., Tseluyko, V.I., Stanislavchuk, M.A., Settas, L., Rosa, J., Ruzga, Z., Povoroznyuk, V.V., Pokrzywnicka-Gajek, I., Petrov, A., Oparanov, B., Mosterova, Z., Kopackova, J., Hrytsenko, H.M., Goranov, I., Dvorak, Z., Bichoversuska, D., Batalov, A., Yoo, B., Yamanaka, H., Wagh, S., Veeravalli, S.C.M., Ueki, Y., Tsai, W.-C., Tohma, S., Tanaka, Y., Takeuchi, T., Takasaki, Y., Shobha, V., Shim, S.C., Rao, U.R., Park, W., Park, S.-H., Ohta, S., Munakata, Y., Mori, S., Miyasaka, N., Miyamoto, T., Migita, K., Liu, M.-F., Liou, L.-B., Lin, H.-Y., Lee, S.-K., Lan, J.-L., Koh, E.-M., Kawabe, Y., Kadel, J.K., Iwahashi, M., Hsu, P.-N., Chopra, A.K., Chandrashekara, S., Bae, S.-C., Amano, K., Adhikari, P., Wolfe, S.M., Wells, A.F., Walsh, B.T., Taborn, J.D., Siva, C., Silverfield, J.C., Sikes, D.H., Shergy, W.J., Shamim, T., Schuette, P.T., Sayers, M.E., Palmer, W.R., Niemer, M.W., Moreland, L.W., Moorman, H.A., Misischia, R.J., Milton, A.C., Mathews, S.D., Longley, S., Kremer, J.M., Kolba, K.S., Kempf, K.J., Katzenstein, P.L., Kaine, J.L., Kafka, S.P., Jackson, R.E., Hill, G.L., Reddy Pasya, S.K., Bouda, D.W., Hargrove, J.K., Halter, D.G., Griffin, R.M., Fleischmann, R.M., Lohr, K.M., Dura, P.A., Diri, E., Dikranian, A.H., Cush, J.J., Brodsky, A.L., Bathon, J.M., Baraf, H.S.B., Birbara, C.A., Thorne, J., Khraishi, M., Keystone, E.C., Niall Jones, H., Haraoui, B., Cividino, A.A., Bessette, L., Baker, M.F., Rischmueller, M., Nicholls, D., Hall, S., Fleischmann, R., Wallenstein, G., Connell, C.A., Gruben, D., Tegzová, D., Song, Y.-W., Nash, P., Cohen, S., Cardiel, M.H., Zerbini, C.A.F., Kremer, J., Tanaka, Y., Keystone, E., Strand, V., van der Heijde, D., Arthritis and Rheumatology, 2019, 10.1002/art.40803

Reply, Pope, J.E., Bykerk, V.P., Thorne, C., Tin, D., Hitchon, C., Hazlewood, G., Boire, G., Bessette, L., Bartlett, S.J., Valois, M.F., Keystone, E.C., Schieir, O., Fatima, S., Arthritis and Rheumatology, 2022, 10.1002/art.41918

Opioid Use and Risk of Nonvertebral Fractures in Adults with Rheumatoid Arthritis: A Nested Case-Control Study Using Administrative Databases, Rahme, E., Bessette, L., Bernatsky, S., Moura, C.S., Acurcio, F.A., Arthritis and Rheumatology, 2016, 10.1002/art.39422

Evaluation of abatacept in biologic-naïve patients with active rheumatoid arthritis, Bessette, L., Schiff, M., Clinical Rheumatology, 2010, 10.1007/s10067-009-1363-0

Comparative Responsiveness of Generic Versus Disease-Specific and Weighted Versus Unweighted Health Status Measures in Carpal Tunnel Syndrome, Katz, J.N., Fossel, A.H., Lew, R.A., Keller, R.B., Kuntz, K.M., Sangha, O., Bessette, L., Medical Care, 1998, 10.1097/00005650-199804000-00005

Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study, Thorne, C., Laliberté, M.-C., Gazel, S., Latour, M.G., Remple, V., Gaetano, T., Donepudi, K., Charland, K., Millson, B., Lebovic, G., Bessette, L., Rheumatology and Therapy, 2018, 10.1007/s40744-018-0109-3

Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials, Ronald F. van Vollenhoven, Phu Vinh On, Tatjana Lukic, Kenneth Kwok, Cassandra D. Kinch, Eduardo Mysler, Louis Bessette, The Journal of Rheumatology, 2022, 10.3899/jrheum.210707

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study, Saeed Shaikh, Jerry Syrotuik, Irina Bogatyreva, Fabienne Staelens, Sami Elmoufti, Derek Haaland, Majed Khraishi, Sanjay Dixit, Isabelle Fortin, Andrew Chow, Boulos Haraoui, Louis Bessette, Therapeutic Advances in Musculoskeletal Disease, 2019, 10.1177/1759720X19831151

Advantages and limitations of utility assessment methods in rheumatoid arthritis, Duru, G., Bombardier, C., Bessette, L., Haraoui, B., Russell, A.S., Beresniak, A., Journal of Rheumatology, 2007

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response, Song, I.-H., Li, Y., Ostor, A., Durez, P., Peterfy, C., Bessette, L., Mysler, E., Enejosa, J.V., Genovese, M.C., Fleischmann, R.M., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2019-215764

Predictors of return to work following carpal tunnel release, Mooney, N., Simmons, B.P., Bessette, L., Punnett, L., Fossel, A.H., Keller, R.B., Katz, J.N., American Journal of Industrial Medicine, 1997, 10.1002/(SICI)1097-0274(199701)31:1<85::AID-AJIM13>3.0.CO;2-3

Recognizing osteoporosis and its consequences in Quebec (ROCQ): Background, rationale, and methods of an anti-fracture patient health-management programme, Brown, J.P., Bessant, J., Baranci, M., Beaulieu, M., Shawn Davison, K., Jean, S., Ste-Marie, L.-G., Bessette, L., Contemporary Clinical Trials, 2008, 10.1016/j.cct.2007.07.007

Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study, Bernatsky, S., Boire, G., Fortin, P.R., Bessette, L., Gamache, P., Hudson, M., Jean, S., Clinical Rheumatology, 2017, 10.1007/s10067-017-3796-1

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study, Song, I.-H., Li, Y., Bu, X., Khan, N., Swierkot, J., Tanaka, Y., Durez, P., Peterfy, C.G., Bessette, L., Mysler, E., Fleischmann, R., RMD Open, 2022, 10.1136/rmdopen-2021-002012

Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression, Jean, S., Brown, J.P., Ste-Marie, L.G., Bessette, L., Gagné, M., Moore, L., Beaudoin, C., Osteoporosis International, 2019, 10.1007/s00198-019-04919-6

Higher comorbidities associated with less improvement in disease activity in early rheumatoid arthritis: results from CATCH cohort, Michel Zummer, Edith Villeneuve, Carter Thorne, Janet Pope, Peter Panopalis, Bindee Kuriya, Ed Keystone, Raman Joshi, Shahin Jamal, Carol Hitchon, Glen Hazlewood, Boulos Haraoui, Derek Haaland, Sabrina Fallavollita, Ines Colmegna, Vivian Bykerk, Gilles Boire, Louis Bessette, Pooneh Akhavan, CATCH investigators, Louis Bessette, Vivian P Bykerk, Hugues Allard-Chamard, Bindee Kuriya, Carter Thorne, Diane Tin, Carol Hitchon, Glen Hazlewood, Gilles Boire, Susan J Bartlett, Marie-France Valois, Orit Schieir, Lillian-Ruiheng Chen, Janet E Pope, Safoora Fatima, Rheumatology, 2025, 10.1093/rheumatology/keaf350

Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis, Bernatsky, S., Bessette, L., Abrahamowicz, M., Maksymowych, W.P., Rahme, E., Moura, C.S., Scandinavian Journal of Rheumatology, 2019, 10.1080/03009742.2018.1470253

Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: Results from the Canadian Early Arthritis Cohort, White, K., Wehlage, A., Vasconcelos, S., Urroz, L., Strecko, J., Sniderman, F., Poirier, N., Papachristos, A., Ouellet, M., McBain, D., Matthews, J., Maguire, L., Magnusson, C., Luc, L., Legge, G., Larsen, T., L'Archevêque, J., Kislinsky, D., Moyen, M., Harrison, T., Harris, B., Guillet, C., Glenn, N., Cottrell, J., Cheng, C., Buchignani, M., Bain, L., Zummer, M., Villeneuve, E., Sutton, E., Shaw, E., Rubin, L., Penney, C., Norris, E., Nair, B., Mosher, D., Menard, H., Lyddell, C., Larche, M., Kraishi, M., Kinkhoff, A., Haraoui, P., Colmegna, I., Cividino, A., Bykerk, V., Bessette, L., Bensen, B., Bell, M., Baron, M., Arbillaga, H., Akhavan, P., Ahluwalia, V., Bykerk, V.P., Thorne, C., Tin, D., Jamal, S., Pope, J., Keystone, E., Haraoui, B., Boire, G., Hitchon, C.A., Rheumatology (United Kingdom), 2016, 10.1093/rheumatology/kew061

Number, Location, and Time Since Prior Fracture as Predictors of Future Fracture in the Elderly From the General Population, Brown, J.P., Ste-Marie, L.-G., Bessette, L., Gamache, P., Moore, L., Jean, S., Beaudoin, C., Journal of Bone and Mineral Research, 2018, 10.1002/jbmr.3526

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial, Pantojas, C., Toro-Torres, R., Soto-Raices, O., Perez-De Jesus, A., Rivera, T.L., Thai, C., Diegel, R.J., Mabaquiao, A.R., Harris, M.D., Mease, P.J., Goddard, D.H., Kimmel, S.C., Sebai, M.B., Mallepalli, J.R., Hull, J.E., Roseff, R., Shanahan, J.C., Scoville, C.D., Sayers, M.E., Querubin, R., Peters, E.A., Mueller, E.C., Klein, S.J., Kivitz, A., Kaine, J.L., Howell, M.P., Greenwald, M., Flint, K.P., Churchill, M.A., Rebroy, A., Ershova, O., Yakushin, S., Stanislav, M., Schmidt, E., Matsievskaya, G., van de Sande, M.G., Tronaru, L., Ramazan, A.M., Opris-Belinski, D., Krogulec, M., Brzezicki, J., Drabiszcak-Piatkowska, J., Plebanski, R., Hrycai, P., Dudek, A., Blicharshi, T., Braun, J., Wagner, S., Neeck, G., Takakubo, Y., Matsui, K., Honjo, S., Goto, H., Atsumi, T., Hatta, K., Matsumoto, Y., Ueki, Y., Inui, K., Dobashi, H., Tada, K., Tsuda, T., Taniguchi, Y., Paimela, L., Karjalainen, A., Jarvinen, P., Eklund, K.K., Pvelka, K., Malcova, M., Dvorak, Z., Dokoupilova, E., Park, M.-C., Lee, S.-H., Lee, S.H., Lee, E.B., Lee, C.K., Kang, S.W., Hong, S.-J., Rodriguez, J.C.R., Remus, C.R.R., Tena, C.F.P., Skinner, C.M., Barragan, S.D., Molina, F.F.C., Rodriguez, A.A.B., Scotton, A.S., Roimicher, L., Melazzi, A.C., Scheinecker, C., Resch, H., Grisar, J., Viola, D.O., Velasco, J., Hidalgo, R.P., Cocco, J.M., Lucero, E., Berman, A., Carrio, J., Ariel, F., Rahman, P., Morin, F., Sieper, J., Carlier, H., Adams, D., Li, X., Gallo, G., Hojnik, M., Leung, A., Tomita, T., Bessette, L., Marzo-Ortega, H., Poddubnyy, D., Østergaard, M., Maksymowych, W.P., Kim, T.-H., Gensler, L.S., van der Heijde, D., Deodhar, A., The Lancet, 2020, 10.1016/S0140-6736(19)32971-X

Response to: "Drugs and cardiovascular risk in inflammatory arthritis: Another case of glucocorticoid-bashing?" by Dr Boers, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Pope, J., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2015-207419

Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks, Deodhar, A., Bessette, L., Zhu, B., Li, X., Sandoval, D., Hunter, T., Baraliakos, X., Wei, J.C.-C., Combe, B., Dougados, M., Strand, V., Navarro-Compán, V., Rahman, P., Mease, P.J., Marzo-Ortega, H., Rheumatology and Therapy, 2020, 10.1007/s40744-020-00225-4

Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis., Dafna Gladman, Robert Inman, Nigil Haroon, Michel Zummer, Rumsey D, Shirley Tse, Glen Hazlewood, Bindu Nair, Elie Karam, Laura Passalent, Lihi Eder, Jonathan Chan, Tristan Boyd, Dianne Mosher, Nicolas Richard, Bessette L, Sibel Zehra Aydin, Mirza R, Jordi Pardo Pardo, Sherry Rohekar, The Journal of rheumatology, 2025, 10.3899/jrheum.2023-1237

High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years, Joshi, R., Jamal, S., Penney, C., Nair, B., Rubin, L., Akhavan, P., Bessette, L., Zummer, M., Haaland, D., Fallavollita, S., Colmegna, I., Baron, M., Villeneuve, É., Morin, F., Bykerk, V.P., Denning, L., Pope, J.E., Tin, D., Keystone, E., Hitchon, C., Haraoui, B., Boire, G., Ahluwalia, V., Bartlett, S.J., Thorne, J.C., Hazlewood, G., Barnabe, C., Marshall, D.A., Lacaille, D., Barber, C.E.H., Schieir, O., Arthritis Care and Research, 2018, 10.1002/acr.23439

Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study, Bernatsky, S., Edworthy, S., Barnabe, C., Peschken, C., Maksymowych, W., Feldman, D., Widdifield, J., Hanly, J.G., Bombardier, C., Bessette, L., Fortin, P.R., Boire, G., Wang, Y., Lacaille, D., Beauchamp, M.-E., Abrahamowicz, M., Moura, C.S., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0713-3

Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort, Pope, J.E., Bykerk, V.P., Thorne, C., Keystone, E., Tin, D., Hitchon, C.A., Hazlewood, G., Boire, G., Bessette, L., Bartlett, S.J., Schieir, O., Holdren, M., Arthritis and Rheumatology, 2021, 10.1002/art.41499

Expression of the myeloid inhibitory receptor CLEC12A correlates with disease activity and cytokines in early rheumatoid arthritis, Fernandes, M.J., Fortin, P.R., Michou, L., Bessette, L., Tessier, P.A., Pelletier, M., Amiable, N., Julien, A.-S., Kerever, A., Lachhab, A., Pagé, N., Paré, G., Desaulniers, P., Vaillancourt, M., Scientific Reports, 2021, 10.1038/s41598-021-90631-7

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials., Deodhar A, Song IH, Kato K, Saffore C, Patrick Zueger, Gao T, Feng D, Maniccia A, Lippe R, Bessette L, de Vlam K, Xenofon Baraliakos, William Tillett, Philip Mease, Andrew Ostor, Iain McInnes, RMD open, 2022, 10.1136/rmdopen-2021-002049

Predictors of outcomes of carpal tunnel release, Bessette, L., Keller, R.B., Fossel, A.H., Amick III, B.C., Losina, E., Katz, J.N., Arthritis and Rheumatism, 2001, 10.1002/1529-0131(200105)44:5<1184::AID-ANR202>3.0.CO;2-A

Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RA., Canadian Early Arthritis Cohort Investigators, Bykerk VP, Bartlett SJ, Janet Pope, Bessette L, Thorne C, Tin D, Hitchon C, Keystone E, Hazlewood G, Boire G, Valois MF, Butler MA, Schieir O, Lee YC, Charis Meng, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2024, 10.1097/rhu.0000000000002091

Rheumatoid arthritis prevalence in Quebec, Joseph, L., Feldman, D.E., Bergeron, L., Belisle, P., Chetaille, A.L., Jean, S., Bessette, L., Fortin, P.R., Boire, G., Pineau, C.A., Hudson, M., Dekis, A., Bernatsky, S., BMC Research Notes, 2014, 10.1186/1756-0500-7-937

Measuring the impact of an educational intervention in rheumatoid arthritis: An open-label, randomized trial., Paul R. Fortin, Chetaille AL, Bessette L, Fortin I, Tremblay JL, Trudeau J, Ikic A, Lui R, Boily G, Côté S, Tardif J, Godbout A, Ratelle L, Légaré J, Holly O. Witteman, Anne-Sophie Julien, Laetitia Michou, Archives of rheumatology, 2021, 10.46497/archrheumatol.2022.8965

Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass, Bone, H.G., MacArios, D., Siddhanti, S., Wagman, R.B., Man, H.-S., Wang, H., Borenstein, J., Varon, S.F., Horne, R., Gold, D.T., Hill, C.D., Kendler, D.L., Bessette, L., Osteoporosis International, 2010, 10.1007/s00198-009-1023-x

Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort, Dougados, M., Haraoui, P., Wendling, D., Claudepierre, P., D'Agostino, M.-A., Michou, L., Bessette, L., Etcheto, A., Moltó, A., Nadon, V., Clinical and experimental rheumatology, 2019

Heterogeneous disease trajectories explain variable radiographic, function and quality of life outcomes in the Canadian Early Arthritis Cohort (CATCH), Lyddell, C., Penney, C., Mosher, D., Hazlewood, G., Nair, B., Ahluwalia, V., Rubin, L., Bensen, W., Akhavan, P., Bessette, L., Baron, M., Zummer, M., Kraishi, M., Bykerk, V.P., Bartlett, S., Keystone, E.C., Pope, J.E., Jamal, S., Curtis, J.R., Van Der Heijde, D., Tin, D., Thorne, J.C., Haraoui, B., Hitchon, C.A., Boire, G., Sun, Y., Barnabe, C., PLoS ONE, 2015, 10.1371/journal.pone.0135327

The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis, Zummer, M., Villeneuve, S., Thorne, C., Tremblay, J.-L., Rubin, L., Pope, J., Penney, C., Nair, B., Lyddell, C., Larche, M., Kuriya, B., Keystone, E., Jamal, S., Hazlewood, G., Haraoui, B., Haaland, D., Fallavollita, S., Colmegna, I., Bykerk, V., Boire, G., Bessette, L., Baron, M., Bartlett, S., Barnabe, C., Barber, C., Barra, L., Akhavan, P., Ahluwalia, V., Bykerk, V.P., Jamal, S., Haraoui, B., Keystone, E.C., Tin, D., Thorne, C.J., Lin, D., Schieir, O., Boire, G., Hitchon, C., Pope, J.E., Barra, L.J., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kew474

Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study., Canadian Tofacitinib for Rheumatoid Arthritis Observational Investigators, Keystone EC, Sampalis JS, Vaillancourt J, Woolcott JC, Gruben D, Roy P, Kinch C, Galos C, Teo M, Lisnevskaia L, Choquette D, Khraishi M, Haraoui B, Arthritis care & research, 2022, 10.1002/acr.24966

Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept., Pope J, Trépanier MO, Dembowy J, Rampakakis E, Haraoui B, Bessette L, Arthritis research & therapy, 2023, 10.1186/s13075-023-03151-2

Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos), Leslie, W.D., Jackson, S.D., Patel, M.S., Lentle, B., Kalyan, S., Prior, J.C., Boyd, S.K., Hanley, D.A., Davison, K.S., Olszynski, W.P., Papaioannou, A., Adachi, J.D., Wong, A.K.O., Josse, R.G., Cheung, A.M., Hopman, W.M., Towheed, T., Anastassiades, T.P., Bessette, L., Brown, J.P., Kaiser, S.M., Kirkland, S., Kovacs, C.S., Joyce, C., Berger, C., Richards, J.B., Rahme, E., Tenenhouse, A., Kreiger, N., Goltzman, D., Rahme, E., Papaioannou, A., Wong, A.K.O., Boyd, S.K., Hanley, D.A., Cheung, A.M., Prior, J.C., Liu, W., Berger, C., Morin, S.N., Archives of Osteoporosis, 2020, 10.1007/s11657-020-00822-4

SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAMME, Burmester, Gerd Rudiger, Enejosa, Jeffrey V., Hendrickson, Barbara, Khan, Nasser, Zhang, Ying, Bessette, Louis, Tanaka, Yoshiya, Zerbini, Cristiano, Winthrop, Kevin, van Vollenhoven, Ronald, Cohen, Stanley B., Rheumatology, 2020

Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study, Derek Haaland, Tanya Girard, Dalinda Liazoghli, Pierre-Andre Fournier, Nicolas Richard, Larissa Lisnevskaia, Andrew Chow, Jonathan Chan, Louis Bessette, Rheumatology and Therapy, 2024, 10.1007/s40744-024-00651-8

The longterm effect of early intensive treatment of seniors with rheumatoid arthritis: A comparison of 2 population-based cohort studies on time to joint replacement surgery, Bernatsky, S., Feldman, D., Hanly, J.G., Bombardier, C., Bessette, L., Fortin, P.R., Boire, G., Beauchamp, M.-E., Huang, A., Michael Paterson, J., Abrahamowicz, M., Wang, Y., Moura, C.S., Widdifield, J., Journal of Rheumatology, 2016, 10.3899/jrheum.151156

COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series., Fortin PR, Sasha Bernatsky, Langlois MA, Panopalis P, Michou L, McCormack D, Hazel E, Fitzcharles MA, Bessette L, Rollet-Labelle E, Flamand L, Rampakakis E, Useche M, Amiable N, Valerio V, Ines Colmegna, RMD open, 2023, 10.1136/rmdopen-2023-003400

Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population, Lelorier, J., Toubouti, Y., Joseph, L., Bessette, L., Beaulieu, M., Choquette, D., Rahme, E., American Journal of Medicine, 2005, 10.1016/j.amjmed.2005.03.026

Classics in spine: Surgery literature revisited, Weinstein, J.N., Lew, R.A., Liang, M.H., Bessette, L., Spine, 1996, 10.1097/00007632-199602010-00001

Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): A systematic literature review of randomized controlled trials, Bykerk, V., Thorne, C., Mosher, D., Leclercq, S., Hochman, J., Haraoui, B., Flanagan, C., Kung, T., Bessette, L., Kalache, F., Barnabe, C., Li, L., Thiessen-Philbrook, H., Pope, J.E., Steiman, A.J., Rheumatology International, 2013, 10.1007/s00296-012-2619-6

Bronchial responsiveness to methacholine in swine confinement building workers, Cormier, W., Tremblay, G., Boulet, L.P., Bessette, L., Archives of Environmental Health, 1993, 10.1080/00039896.1993.9938397

Validation of a clinical definition for fragility fracture, Ste-Marie, Louis-Georges, Bessant, Jennifer, Beaulieu, Michele, Davison, K. Shawn, Jean, Sonia, Bessette, Louis, Brown, Jacques P., The Journal of Rheumatology, 2008

Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada, Lachaine, J., Légaré, J., Bernatsky, S., Rahme, E., Bessette, L., Roussy, J.-P., Rheumatology International, 2014, 10.1007/s00296-013-2828-7

Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate, Pelletier, J.-P., Wildi, L.M., Morin, F., Bessette, L., Beaulieu, A., Abram, F., Choquette, D., Haraoui, B., Dorais, M., Martel-Pelletier, J., Raynauld, J.-P., Cartilage, 2013, 10.1177/1947603513483547

Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis Cohort, Bartlett, Susan J., Bykerk, Vivian P., Keystone, Edward C., Tin, Diane, Boire, Gilles, Pope, Janet, Thorne, Carter, Hazlewood, Glen, Bessette, Louis, Hitchon, Carol, Colmegna, Ines, Valois, Marie-France, Schieir, Orit, Ta, Viviane, ACR Open Rheumatology, 2022, 10.1002/ACR2.11427

The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study, Paul R. Fortin, Sonia Lagacé, Marie-Claude Audet, Philippe Desaulniers, Louis Bessette, Nathalie Amiable, Anne-Sophie Julien, Caroline Sirois, William Berthelot, Rheumatology International, 2025, 10.1007/s00296-025-05804-8

A quarter of patients time their early rheumatoid arthritis onset differently than physicians, Pope, J., Bykerk, V.P., Thorne, C., Tin, D., Keystone, E., Hitchon, C., Hazlewood, G.S., Boire, G., Bessette, L., Bartlett, S.J., Schieir, O., Kudaeva, F., Ellingwood, L., RMD Open, 2019, 10.1136/rmdopen-2019-000931

Rates of non-vertebral osteoporotic fractures in rheumatoid arthritis and postfracture osteoporosis care in a period of evolving clinical practice guidelines, Lachaine, J., Rahme, E., Bernatsky, S., Bessette, L., Roussy, J.-P., Calcified Tissue International, 2014, 10.1007/s00223-014-9856-5

The burden of illness of osteoporosis in Canada, Goeree, R., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S., Leslie, W.D., Hopkins, R.B., Tarride, J.-E., Osteoporosis International, 2012, 10.1007/s00198-012-1931-z

INFECTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB, Asin-Milan, Odalis, Nantel, Francois, Rachich, Meagan, Lehman, Allen J., Rampakakis, Emmanouil, Purvis, Jane, Kelsall, John, Rahman, Proton, Bessette, Louis, Internal Medicine Journal, 2020

“From Where I Stand”: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ), M Zummer, E Villeneuve, L Rubin, P Panopoulos, B Nair, R Joshi, S Jamal, B Haraoui, D Haaland, S Fallavollita, I Colmegna, M Baron, Clifton O. Bingham, III, Diane Tin, Carter Thorne, Edward Keystone, Louis Bessette, Glen Hazlewood, Carol Hitchon, Gilles Boire, Janet E. Pope, Marie-France Valois, Orit Schieir, Vivian P. Bykerk, Susan J. Bartlett, Quality of Life Research, 2023, 10.1007/s11136-022-03227-7

Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study., Mysler E, Tanaka Y, Peterfy CG, Li Y, Khan N, Bessette L, Bu X, patrick durez, Penn SK, Swierkot J, Roy Fleischmann, RMD open, 2024, 10.1136/rmdopen-2023-004007

Real-world validation of the minimal disease activity index in psoriatic arthritis: An analysis from a prospective, observational, biological treatment registry, Tkaczyk, C., Osborne, B., Nantel, F., Lehman, A.J., Psaradellis, E., Rampakakis, E., Kapur, S., Kelsall, J., Chow, A., Haraoui, B., Baer, P., Bessette, L., Zummer, M., Rahman, P., BMJ Open, 2017, 10.1136/bmjopen-2017-016619

Prediction of Osteoporotic Fractures in Elderly Individuals: A Derivation and Internal Validation Study Using Healthcare Administrative Data, Jacques P. Brown, Louis-Georges Ste-Marie, Louis Bessette, Philippe Gamache, Lynne Moore, Sonia Jean, Claudia Beaudoin, Journal of Bone and Mineral Research, 2020, 10.1002/jbmr.4438

APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS, Asin-Milan, Odalis, Nantel, Francois, Rachich, Meagan, Lehman, Allen J., Rampakakis, Emmanouil, Anderson, Keltie, Rahman, Proton, Keystone, Ed, Bessette, Louis, Internal Medicine Journal, 2020

Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort., CATCH Investigators , Lillian, Bykerk V, Valois MF, Tin D, Thorne C, Schieir O, Edward keystone, Glen Hazlewood, Hitchon CA, Bessette L, Gilles Boire, Susan J. Bartlett, Janet Pope, Stranges S, Hadwen B, Rheumatology advances in practice, 2024, 10.1093/rap/rkae066

Expectations and educational needs of rheumatologists, rheumatology fellows and patients in the field of precision medicine in Canada, a quantitative cross-sectional and descriptive study, Michou, L., Dogba, M.J., Lacaille, D., Fortin, P.R., Bessette, L., Légaré, J., Simonyan, D., Ruel-Gagné, S., BMC Rheumatology, 2021, 10.1186/s41927-021-00222-2

Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study, Thorne, J.C., Laliberté, M.-C., Latour, M.G., Gazel, S., Gaetano, T., Millson, B., Glass, J., Lebovic, G., Shear, N.H., Bessette, L., Marshall, J.K., Clinical Therapeutics, 2018, 10.1016/j.clinthera.2018.04.017

Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs., Seoyoung Kim, Lily G. Bessette, He M, Desai RJ, Ajinkya Pawar, ACR open rheumatology, 2021, 10.1002/acr2.11292

Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs., Bessette L, Florica B, Stewart JC, Silverberg S, Remple VP, Majed Khraishi , The Journal of rheumatology, 2022, 10.3899/jrheum.200609

Découvrez nos professeurs et professeures!

Louis Bessette

Contribution à la recherche

Thématiques de recherche de la Faculté de médecine

Publications

Vice-décanat à la recherche et à l'innovation